Aromatic L-amino Acid Decarboxylase Inhibitors

All categories
DBCAT005152Pharmacologic class

Aromatic L-amino acid decarboxylase is the enzyme responsible for the conversion of L-DOPA to dopamine. Inhibitors of this enzyme are typically unable to cross the blood-brain-barrier, meaning they remain in the periphery and inhibit peripheral... A DrugBank category of 3 drugs. 3 of them are approved.

Part of
Enzyme Inhibitors
Also known as
DOPA decarboxylase inhibitor
Drugs

What you can answer from here — as of April 15, 2020

3DrugsEach linked to its full drug card
Listed above
4Drug targetsEvery drug–target pair in the class, with bond type
Sign in
1,640Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
6Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Aromatic L-amino Acid Decarboxylase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In